Company No:
Contents
| Note | 2025 | 2024 | ||
| £ | £ | |||
| Fixed assets | ||||
| Tangible assets | 3 |
|
|
|
| Biological assets | 4 | 575,457 | 589,280 | |
| 4,308,500 | 3,848,786 | |||
| Current assets | ||||
| Stocks | 5, 6 |
|
|
|
| Debtors | 7 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 880,021 | 1,025,859 | |||
| Creditors: amounts falling due within one year | 8 | (
|
(
|
|
| Net current assets | 485,296 | 558,233 | ||
| Total assets less current liabilities | 4,793,796 | 4,407,019 | ||
| Creditors: amounts falling due after more than one year | 9 | (
|
(
|
|
| Provision for liabilities | (
|
(
|
||
| Net assets |
|
|
||
| Capital and reserves | ||||
| Called-up share capital |
|
|
||
| Profit and loss account |
|
|
||
| Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of Luscombe Farms Limited (registered number:
|
Mr A P Luscombe
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Luscombe Farms Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Goodwood House, Blackbrook Park Avenue, Taunton, TA1 2PX, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date that are expected to apply when the timing differences reverse. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax liabilities are presented within provisions for liabilities on the balance sheet.
| Land and buildings | 0 -
|
| Plant and machinery |
|
| Vehicles | 15 -
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Biological assets held for continuing use within the business are classified as fixed assets. Such assets are measured at cost less accumulated depreciation and impairment. Assets within the classification comprise a dairy herd.
Biological assets not held for continuing use within the business are classified as current assets. Such assets are measured at cost less accumulated impairment. Assets within this classification comprise dairy followers and recognised within stock.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a financing transaction it is measured at cost. Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in other operating income over the period in which the related costs are recognised, and timing differences are presented as other debtors or deferred income within the balance sheet. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.
Profit and loss account includes all current and prior period profits and losses, less any distributed dividend.
| 2025 | 2024 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including directors |
|
|
| Land and buildings | Plant and machinery | Vehicles | Total | ||||
| £ | £ | £ | £ | ||||
| Cost | |||||||
| At 01 April 2024 |
|
|
|
|
|||
| Additions |
|
|
|
|
|||
| Disposals |
|
|
(
|
(
|
|||
| At 31 March 2025 |
|
|
|
|
|||
| Accumulated depreciation | |||||||
| At 01 April 2024 |
|
|
|
|
|||
| Charge for the financial year |
|
|
|
|
|||
| Disposals |
|
|
(
|
(
|
|||
| At 31 March 2025 |
|
|
|
|
|||
| Net book value | |||||||
| At 31 March 2025 | 2,827,613 | 649,422 | 256,008 | 3,733,043 | |||
| At 31 March 2024 | 2,820,565 | 212,843 | 226,098 | 3,259,506 |
| 2025 | |
| £ | |
| Biological assets at cost |
|
Assets held at cost:
|
|
Total | ||
| £ | £ | ||
| Cost | |||
| At 01 April 2024 |
|
|
|
| Increase due to purchases/ transfers in |
|
|
|
| Decrease attributable to sales/ transfers out | (
|
(
|
|
| At 31 March 2025 |
|
|
|
| Accumulated depreciation | |||
| At 01 April 2024 |
|
|
|
| At 31 March 2025 |
|
|
|
| Net book value | |||
| At 31 March 2025 |
|
|
|
| At 31 March 2024 |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Livestock |
|
|
|
| Other stock |
|
|
|
|
|
|
Assets held at cost:
| Dairy | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 April 2024 | 225,022 | 225,022 | |
| Increase due to purchases/ transfers in | 51,104 | 51,104 | |
| At 31 March 2025 | 276,126 | 276,126 | |
| 2025 | 2024 | ||
| £ | £ | ||
| Trade debtors |
|
|
|
| Other debtors |
|
|
|
|
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Bank loans |
|
|
|
| Trade creditors |
|
|
|
| Taxation and social security |
|
|
|
| Other creditors |
|
|
|
|
|
|
Included within other creditors are amounts owed to the directors, accruals, and other immaterial creditors.
| 2025 | 2024 | ||
| £ | £ | ||
| Bank loans (secured) |
|
|
The directors loan accounts are repayable on demand and interest has been charged on overdrawn balances exceeding £10,000 at the official HMRC rates.
At 1 April 2024 the balance owed from the directors was £nil. During the year, the company made advances to directors amounting to £86,513 and received repayments of £40,530 leaving a balance due from the directors of £45,983 at 31 March 2025.
At 1 April 2023 the balance owed from the directors was £nil. During the year, the company made advances to directors amounting to £23,486 and received repayments of £23,486 leaving a balance due from the directors of £nil.